UnitedHealthcare Airway Clearance Coverage Update

Coverage and Medical Necessity Criteria

Applicable Medical Necessity Criteria References

Coverage follows state-specific or referenced criteria:

State-specific chest wall oscillation: Medical necessity clinical coverage criteria for chest wall oscillation are those in the Idaho Medicaid Provider Handbook, Provider Guidelines, Durable Medical Equipment, Prosthetics, Orthotics and Supplies: Chest Wall Oscillation Device.

Refer to Idaho Medicaid Provider Handbook for detail.

Other airway clearance devices: Medical necessity criteria for airway clearance devices other than chest wall oscillation reference InterQual® Client Defined, CP: Durable Medical Equipment, Airway or Secretion Clearance Devices (Custom) - UHG.

InterQual criteria to be applied as specified.

Not Medically Necessary / Unproven

Devices considered not medically necessary

Unproven devices: Combination continuous positive expiratory pressure (PEP), continuous high-frequency oscillation, and nebulized medication therapy devices for oscillation and lung expansion (OLE) are considered unproven and not medically necessary.

Document states these are unproven and not medically necessary.

Intrapulmonary percussive ventilation (home): Intrapulmonary percussive ventilation devices for home use are considered unproven and not medically necessary.

Document explicitly classifies home IPV as unproven and not medically necessary.

General medical necessity considerations

Coverage and medical necessity are informed by available clinical evidence summarized below; policy emphasizes individualized assessment and use of InterQualae criteria where applicable.

Evidence-based coverage considerations: For a device or therapy to be considered medically necessary, providers should document clinical rationale including diagnosis, prior therapies, ability to perform other airway clearance techniques (ACTs), and demonstrable need for external chest manipulation or device-based oscillation. Available evidence is generally low to very low quality for superiority of oscillating devices over other ACTs; select populations (for example, high-risk perioperative patients) have shown potential benefit in reducing postoperative pulmonary complications and resource use.

See supporting studies: Huynh et al. (OLE), Hassan et al. (IPV)

Condition-specific considerations

Population- and technique-specific guidance

Cystic fibrosis or bronchiectasis: Systematic reviews and clinical guidelines (ACCP, NICE) find insufficient evidence that any airway clearance technique is consistently superior; selection should be guided by individualized assessment, patient preference, and ability to clear secretions. Consider training and regular reassessment of ACT effectiveness.

NICE and ACCP guidance referenced.

Perioperative/high-risk surgery: In a multicenter prospective study of high-risk surgical patients, OLE treatment was associated with reduced postoperative pulmonary complications, shorter ventilator time, and shorter hospital length of stay; however, well-designed controlled trials are needed to confirm effectiveness.

Huynh et al. OLE study findings.

IPV

IPV evidence summary and implications

IPV inpatient use: Randomized trials and systematic reviews report modest inpatient benefits of IPV in selected critically ill populations (e.g., reduced ICU length of stay, small improvements in oxygenation and respiratory rate), but evidence is heterogeneous and overall weak. Routine long-term home use of IPV is not supported by sufficient high-quality evidence.

Hassan et al. RCT 2024 and IPV systematic reviews show limited, low-quality evidence.

Combination oscillation and lung expansion (OLE) devices refer to systems that combine continuous positive expiratory pressure, continuous high-frequency oscillation, and nebulized medication therapy. The policy classifies these combination OLE devices as unproven and therefore not medically necessary for home use. This determination reflects currently available evidence, which is low to very low quality and does not demonstrate clear superiority of oscillating combination devices over other airway clearance techniques.

Routine use of oscillating devices cannot be recommended based on the current evidence base. Systematic reviews report low- or very low-certainty findings, inconsistent patient preference and adherence data, and no clear evidence that oscillation is consistently more effective than other airway clearance techniques. Coverage decisions should therefore be individualized, supported by documentation of clinical rationale, prior therapies, and inability or intolerance of standard airway clearance techniques, and follow the applicable state- or InterQual-referenced medical necessity criteria as specified in this policy.

Both combination OLE devices and intrapulmonary percussive ventilation (IPV) devices for home use are explicitly described in this policy as unproven and not medically necessary. Requests for these devices for routine home use will not meet coverage criteria under this policy absent compelling new evidence or a state-specific exception.

Although some inpatient and critical care studies of IPV report modest short-term benefits (for example reductions in ICU length of stay and small improvements in oxygenation and respiratory rate), systematic reviews conclude the evidence is weak, heterogeneous, and insufficient to support long-term home use of IPV devices. Consequently, long-term home IPV is considered not medically necessary in the absence of stronger, higher-quality evidence and individualized clinical justification.

DME Medical Necessity Determination

Apply referenced criteria to determine medical necessity:

Chest wall oscillation devices (Idaho): Coverage and medical necessity for chest wall oscillation devices are determined per the Idaho Medicaid Provider Handbook chest wall oscillation device criteria.

See state handbook.

Other airway clearance devices: For airway clearance devices other than chest wall oscillation, apply InterQual® Client Defined CP: Durable Medical Equipment, Airway or Secretion Clearance Devices (Custom) - UHG to determine medical necessity.

InterQual referenced.

HFCWO / OLE / IPV medical necessity nodes

Device may be considered when ALL of the following clinical circumstances are met:

Codes and Diagnosis Guidance

Applicable HCPCS/CPT codesHCPCS

A7021	Supplies and accessories for lung expansion airway clearance, continuous high frequency oscillation, and nebulization device (e.g., handset, nebulizer kit, biofilter).
A7025	High frequency chest wall oscillation system vest, replacement for use with patient- owned equipment, each.
A7026	High frequency chest wall oscillation system hose, replacement for use with patient- owned equipment, each.
E0469	Lung expansion airway clearance, continuous high frequency oscillation, and nebulization device.
E0481	Intrapulmonary percussive ventilation system and related accessories.
E0483	High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation includes all accessories and supplies, each.

Applicable ICD-10 Diagnosis Codes (selection)ICD-10

E84.0	Cystic fibrosis with pulmonary manifestations.
J47.9	Bronchiectasis, uncomplicated.
G12.21	Amyotrophic lateral sclerosis.
G12.1	Other inherited spinal muscular atrophy.
G71.00	Muscular dystrophy, unspecified.
Z99.11	Dependence on respirator [ventilator] status.

Applicable HCPCS (noted)HCPCS

E0481

High-frequency chest wall oscillation (example HCPCS)

Added ICD-10 diagnosis codesICD-10

G35.A	ICD-10 diagnosis code added to policy
G35.B0	ICD-10 diagnosis code added to policy
G35.B1	ICD-10 diagnosis code added to policy
G35.B2	ICD-10 diagnosis code added to policy
G35.C0	ICD-10 diagnosis code added to policy
G35.C1	ICD-10 diagnosis code added to policy
G35.C2	ICD-10 diagnosis code added to policy
G35.D	ICD-10 diagnosis code added to policy
G71.036	ICD-10 diagnosis code added to policy

Coding

HCPCS/CPT codes referencedE0469, E0481, E0483, A7021, A7025, A7026 (listed for reference; inclusion does not guarantee coverage).

Action for prior authorizationInclusion of codes may trigger prior auth; apply medical necessity and state/contract rules.

State-specific noteCoverage and application of these codes are subject to state program fee schedules and contract terms (e.g., Idaho Medicaid exclusions).

Code purpose examplesE0469: lung expansion airway clearance device; E0483: HFCWO system; E0481: IPV system and accessories.

Provider Actions and Authorization Guidance

Note

Applicable Codes

The following list(s) of procedure and/or diagnosis codes is provided for reference purposes only and may not be all inclusive. Listing of a code in this policy does not imply that the service described by the code is a covered or non‑covered health service. Benefit coverage for health services is determined by federal, state, or contractual requirements and applicable laws that may require coverage for a specific service. The inclusion of a code does not imply any right to reimbursement or guarantee claim payment. Other Policies and Guidelines may apply.

A7021 — Supplies and accessories for lung expansion airway clearance, continuous high frequency oscillation, and nebulization device (e.g., handset, nebulizer kit, biofilter)
A7025 — High frequency chest wall oscillation system vest, replacement for use with patient‑owned equipment, each
A7026 — High frequency chest wall oscillation system hose, replacement for use with patient‑owned equipment, each
E0469 — Lung expansion airway clearance, continuous high frequency oscillation, and nebulization device
E0481* — Intrapulmonary percussive ventilation system and related accessories
E0483 — High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation; includes all accessories and supplies, each

Device and Therapy Definitions

Intrapulmonary percussive ventilation — definition and mechanism

DefinitionIntrapulmonary percussive ventilation (IPV) is a mechanized form of chest physical therapy that delivers >200 mini‑bursts per minute of respiratory gases to the lungs via a mouthpiece to mobilize endobronchial secretions and treat patchy atelectasis.

MechanismDelivers rapid percussive breaths with adjustable inspiratory time, delivery rates, and peak pressure to augment secretion mobilization.

Clinical contextsUsed in therapist‑delivered and home settings in description, but evidence does not support routine long‑term home use.

OLE devices (Oscillation and Lung Expansion) — combination device definition

DefinitionOLE devices combine continuous positive expiratory pressure (PEP), continuous high‑frequency oscillation, and nebulized medication therapy into a single oscillation and lung expansion system.

Documentation Requirements

Documentation Required

Provide complete, legible medical documentation to support necessity

Provide complete medical documentation to support medical necessity for coverage requests — include history, relevant physical exam findings, and results of pertinent diagnostic tests or procedures; documentation must be legible and available upon request.

Examples: relevant medical history, physical examination findings, diagnostic test results.

Documentation Required

Include history, exam, and diagnostic results to support the coverage request

When requesting coverage, include medical record documentation that demonstrates the member meets clinical criteria: relevant history, physical exam, and diagnostic test/procedure results. Documentation must fully support the medical necessity determination.

Documentation may be requested to assess whether clinical criteria are met and does not guarantee coverage.

Services and Devices Not Covered

Combination OLE devices and home intrapulmonary percussive ventilation systems are listed as not covered by this policy because they are considered unproven and not medically necessary for routine home use. Inclusion of device codes in the policy code list does not imply coverage when the device is characterized here as unproven.

Routine long-term home use of IPV devices is not supported by adequate high-quality evidence and is therefore described as not covered. Additionally, providers should note that HCPCS code E0481 may not be covered under Idaho Medicaid because it is not on the State of Idaho Medicaid Fee Schedule; such requests may be denied by that program.

Rental, Purchase and State Rules

HCPCS Code	Description / Rule	Coverage
E0481	Intrapulmonary percussive ventilation system and related accessories — coverage and purchase vs rental dependent on applicable state program fee schedule; NOT on the State of Idaho Medicaid Fee Schedule and therefore may not be covered by Idaho Medicaid.	dependent on state program fee schedule

Replacement and Repair Guidance

Replacement

Replacement intervalsNo replacement interval specified in policy; replacement schedules are dependent on state program rules and manufacturer guidance.

Documentation for replacementMedical records must justify replacement requests with clinical documentation demonstrating ongoing medical necessity.

State fee‑schedule impactCoverage for replacement or purchase may be influenced by state fee schedules (e.g., Idaho Medicaid provisions).

Background and Evidence Summary

Intrapulmonary percussive ventilation (IPV) is a mechanized form of chest physiotherapy that delivers rapid mini-bursts of gas via a mouthpiece (often >200 per minute) to mobilize endobronchial secretions and treat patchy atelectasis. Clinical studies have examined IPV primarily in inpatient or critical care settings; some randomized trials and systematic reviews report modest improvements in ICU length of stay, oxygenation, and respiratory rate, but the overall evidence is weak, heterogeneous, and limited in sample size and generalizability. Because of these limitations, the policy does not support routine long-term home IPV use and considers home IPV unproven and not medically necessary.

OpenPayer

Airway Clearance Devices (Idaho Only)